gptkbp:instance_of
|
gptkb:patches
|
gptkbp:administered_by
|
licensed healthcare professional
|
gptkbp:approves
|
gptkb:2013
gptkb:FDA
|
gptkbp:brand
|
gptkb:Allergan
|
gptkbp:clinical_trial
|
Phase 3
cheek augmentation
facial contouring
wrinkle treatment
VOLUMA study
VOLUMA XC study
|
gptkbp:clinical_use
|
gptkb:cosmetics
|
gptkbp:contains
|
hyaluronic acid
|
gptkbp:contraindication
|
pregnancy
breastfeeding
active skin infection
allergy to hyaluronic acid
|
gptkbp:customer_satisfaction
|
high
|
gptkbp:duration
|
up to 2 years
|
gptkbp:duration_of_procedure
|
30 minutes
|
gptkbp:duration_of_results
|
up to 24 months
|
gptkbp:events
|
recommended after 2 weeks
|
gptkbp:formulation
|
gptkb:gel
|
gptkbp:frequency
|
as needed
|
https://www.w3.org/2000/01/rdf-schema#label
|
Voluma XC
|
gptkbp:is_effective_against
|
high
|
gptkbp:manufacturer
|
gptkb:Allergan,_Inc.
|
gptkbp:marketed_as
|
gptkb:Europe
gptkb:Canada
gptkb:United_States
Voluma
|
gptkbp:packaging
|
syringe
|
gptkbp:patient_population
|
gptkb:women
men
|
gptkbp:provides_guidance_on
|
avoid alcohol
avoid excessive sun exposure
avoid strenuous exercise
|
gptkbp:recovery_method
|
minimal
|
gptkbp:reversible
|
gptkb:true
|
gptkbp:side_effect
|
bruising
swelling
redness
itching
pain at injection site
discoloration
lumps
vascular occlusion
|
gptkbp:storage
|
room temperature
|
gptkbp:target_audience
|
adults
|
gptkbp:type
|
injectable filler
|
gptkbp:used_for
|
facial volume restoration
|
gptkbp:volume_per_syringe
|
1 ml
|
gptkbp:website
|
gptkb:temples
cheeks
jawline
bolus technique
linear threading
|
gptkbp:bfsParent
|
gptkb:Juvederm_Voluma
|
gptkbp:bfsLayer
|
7
|